Health IssuesIssues related to the implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to women's health; Issues related to oncology; Issues related to ophthalmology; Issues related to the One Big Beautiful Bill Act (PL 119-21).Lobbied: HOUSE OF REPRESENTATIVES, SENATE
Medicare/MedicaidIssues related to the implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the One Big Beautiful Bill Act (PL 119-21).Lobbied: HOUSE OF REPRESENTATIVES, SENATE
The report’s record: the firm and its client, the income or expenses, each issue with the report’s own words and the agencies lobbied, and every amendment.
Source: lda.gov, the Secretary of the Senate’s and the Clerk of the House’s Lobbying Disclosure Act reports, read . Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.